Black Rock Inc. Larimar Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,134,050 shares of LRMR stock, worth $18.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,134,050

Previous 2,338,862 34.0%

Holding current value

$18.5 Million

Previous $17.8 Million 28.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.33 - $9.89 $5.03 Million - $7.86 Million	795,188 Added 34.0%	3,134,050 $22.7 Million
Q1 2024 May 10, 2024	BUY	$4.2 - $13.28 $2.82 Million - $8.91 Million	670,817 Added 40.22%	2,338,862 $17.8 Million
Q4 2023 Feb 13, 2024	BUY	$2.35 - $4.71 $374,190 - $749,973	159,230 Added 10.55%	1,668,045 $7.59 Million
Q3 2023 Nov 13, 2023	BUY	$3.08 - $4.49 $217,238 - $316,688	70,532 Added 4.9%	1,508,815 $5.96 Million
Q2 2023 Aug 11, 2023	BUY	$3.13 - $5.27 $3.49 Million - $5.88 Million	1,115,152 Added 345.11%	1,438,283 $4.5 Million
Q1 2023 May 12, 2023	BUY	$4.0 - $6.68 $123,252 - $205,830	30,813 Added 10.54%	323,131 $1.46 Million
Q4 2022 Feb 13, 2023	BUY	$2.73 - $5.08 $151,656 - $282,204	55,552 Added 23.46%	292,318 $1.21 Million
Q3 2022 Nov 14, 2022	SELL	$1.53 - $3.64 $8,173 - $19,444	-5,342 Reduced 2.21%	236,766 $757,000
Q2 2022 Aug 12, 2022	SELL	$1.9 - $3.98 $7,121 - $14,917	-3,748 Reduced 1.52%	242,108 $475,000
Q1 2022 May 12, 2022	BUY	$3.65 - $10.84 $3,500 - $10,395	959 Added 0.39%	245,856 $996,000
Q4 2021 Feb 10, 2022	BUY	$8.86 - $13.47 $26,845 - $40,814	3,030 Added 1.25%	244,897 $2.64 Million
Q3 2021 Nov 09, 2021	SELL	$9.61 - $15.11 $96,417 - $151,598	-10,033 Reduced 3.98%	241,867 $2.79 Million
Q2 2021 Aug 11, 2021	BUY	$8.0 - $15.2 $2.02 Million - $3.83 Million	251,900 New	251,900 $2.47 Million

Others Institutions Holding LRMR

# of Institutions

128

Shares Held

67.3M

Call Options Held

280K

Put Options Held

76.3K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $256M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account